Background: The novel coronavirus began in Wuhan, China in December 2019. As a result of its rapid spread to other parts of the world, the World Health Organization (WHO) declared the virus as a pandemic on March 11, 2020. Infected individuals can manifest the signs and symptoms ranging from fever, dry cough, headache, and respiratory distress. Other documented clinical features include sore throat, fatigue, lethargy, diarrhea, and chest tightness, while some other infected persons may remain asymptomatic throughout the incubation period with the ability to transmit the infection to others, with incubation period of COVID-19 being between 2 and 14 days. The timing of elective surgery after recovery from covid_19 utilizes both symptom and severity-based categories. Four weeks for an asymptomatic patient. Six weeks for a symptomatic patient (e.g. cough, dyspnea). Aim of work: The goal of this essay is to provide the anesthesia care provider with an understanding of the basics, clinical aspects and recent advances of anesthesia management and perioperative infection control in coronavirus patients in order to diminish related morbidity and to avoid adverse perioperative event. Conclusion: The use of regional anaesthesia during the COVID-19 pandemic should be the preferred method of anaesthesia, whenever possible. In addition to its many benefits in the prevention of postoperative complications, the appropriate regional technique can preserve respiratory function and avoid aerosolization and airway instrumentation to prevent viral transmission.